These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8584586)

  • 21. Early detection and intervention in schizophrenia.
    Linszen DH; Dingemans PM; Lenior ME; Scholte WF; de Haan L; Goldstein MJ
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S31-4. PubMed ID: 9690968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsychotic medication in the treatment of schizophrenia.
    Kane JM
    Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose depot medication in schizophrenia.
    Burnett PL; Galletly CA; Moyle RJ; Clark CR
    Schizophr Bull; 1993; 19(1):155-64. PubMed ID: 8095736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of relapse in chronic schizophrenic patients.
    Hogarty GE
    J Clin Psychiatry; 1993 Mar; 54 Suppl():18-23. PubMed ID: 8097193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conventional antipsychotic medications for schizophrenia.
    Dixon LB; Lehman AF; Levine J
    Schizophr Bull; 1995; 21(4):567-77. PubMed ID: 8749885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing dosage in maintenance treatment of schizophrenia. Review and prognosis.
    Schooler NR
    Br J Psychiatry Suppl; 1993 Dec; (22):58-65. PubMed ID: 7906525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR; McEvedy CJ; Nelson HE
    Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of targeted intervention and maintenance pharmacotherapy in conjunction with family intervention in schizophrenia.
    Wiedemann G; Hahlweg K; Müller U; Feinstein E; Hank G; Dose M
    Eur Arch Psychiatry Clin Neurosci; 2001; 251(2):72-84. PubMed ID: 11407442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of schizophrenia.
    Kane JM
    Schizophr Bull; 1987; 13(1):133-56. PubMed ID: 2885912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The social status of schizophrenic patients].
    Müller P; Gaebel W; Bandelow B; Köpcke W; Linden M; Müller-Spahn F; Pietzcker A; Tegeler J
    Nervenarzt; 1998 Mar; 69(3):204-9. PubMed ID: 9565974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia.
    Schooler NR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent vs maintenance medication in schizophrenia. Two-year results.
    Herz MI; Glazer WM; Mostert MA; Sheard MA; Szymanski HV; Hafez H; Mirza M; Vana J
    Arch Gen Psychiatry; 1991 Apr; 48(4):333-9. PubMed ID: 1672588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Psychoeducational-psychotherapeutic treatment of schizophrenic patients and their caregivers. Results of a 1-year catamnestic study].
    Hornung WP; Holle R; Schulze Mönking H; Klingberg S; Buchkremer G
    Nervenarzt; 1995 Nov; 66(11):828-34. PubMed ID: 8532099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expressed emotion, communication deviance and schizophrenia. An exploratory study of the relationship between two family variables and the course and outcome of a psychoeducational treatment programme.
    Rund BR; Oie M; Borchgrevink TS; Fjell A
    Psychopathology; 1995; 28(4):220-8. PubMed ID: 7480578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosocial treatments for schizophrenia.
    Liberman RP
    Psychiatry; 1994 May; 57(2):104-14. PubMed ID: 7938330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication.
    de Haan L; Linszen DH; Lenior ME; de Win ED; Gorsira R
    Schizophr Bull; 2003; 29(2):341-8. PubMed ID: 14552508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deliverability of psychoeducational family management.
    Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
    Schizophr Bull; 1994; 20(3):547-56. PubMed ID: 7973470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Specialised first-episode psychosis services: a systematic review of the literature].
    Skalli L; Nicole L
    Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication adherence studies in schizophrenia.
    Hamann J; Pitschel-Walz G; Kissling W
    Am J Psychiatry; 2004 Mar; 161(3):582; author reply 582-3. PubMed ID: 14992997
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.